Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.
Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people’s lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world’s leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.
For more information, visit www.amgen.com.
UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. With more than 7,500 people in approximately 40 countries, the company generated revenue of € 4.5 billion in 2017. UCB is listed on Euronext Brussels (symbol: UCB). Follow us on Twitter: @UCB_news
Our mission is to discover new ways to improve and extend people`s lives. Our vision is to be a trusted leader in changing the practice of medicine.
We use science-based innovation to address some of society’s most challenging healthcare issues. We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible.
Bone Therapeutics is a leading biotechnology company specializing in the development of cell therapy products for orthopaedics and bone diseases.
Its unique technology allows to produce biologically active bone cells that are able to regenerate a healthy bone environment and promote bone regeneration.
The product candidates have been developed for the treatment of indications with high unmet medical needs such as degenerative diseases of the spine, severe unhealed fractures and osteonecrosis of the hip.
The products, administrable through a minimally invasive percutaneous approach without open surgery, do not require long hospitalization, have already shown encouraging clinical results and address important unmet medical needs.
High-performance scientific instruments and analytical and diagnostic solutions to explore life and materials at molecular level.
The Research Foundation – Flanders (FWO) is the agency that supports ground-breaking fundamental and strategic research at the universities of the Flemish Community. The FWO also stimulates cooperation between the Flemish universities and other research institutes.
Takeda is a patient-focused, values-based, R&D-driven global biopharmaceutical company committed to bringing Better Health and a Brighter Future to people worldwide. Our passion and pursuit of potentially life-changing treatments for patients are deeply rooted in over 230 years of distinguished history in Japan.
Helping people to live healthier is the core of everything we do. After all, mankind has the genetic potential to live a healthy lifestyle. Metagenics helps to reach this potential through nutrition. That is why we have developed our original products and nutritional concepts for young and old. That is why we are dedicated to helping healthcare professionals offer safe, effective and more natural solutions to their patients.